Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020


 

Treatment of Metastatic Urothelial Carcinoma: Frontline Chemo, IO in 1st Line and 2nd Line Setting, Enfortumab Vedotin in Post IO Setting & Erdafitinib for Patients With FGFR Alterations

254 views
February 26, 2020
0 Comments
Login to view comments. Click here to Login
Updates in Oncology